Navigation Links
Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial
Date:9/24/2009

ma, please go to www.cancer.org.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase 1/2 and Phase 2 human trials using REOLYSIN, its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit www.oncolyticsbiotech.com

The Cancer Therapy Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the nation's leading academic research and treatment centers, serving more than 4.4 million people in the high-growth corridor of Central and South Texas including Austin, San Antonio, Laredo and the Rio Grande Valley. CTRC is one of a few elite cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only three in Texas. A world leader in developing new drugs to treat cancer, The CTRC Institute for Drug Development (IDD) is internationally recognized for conducting the largest oncology Phase I clinical drug trials program in the world, and participates in the clinical and/or preclinical development of many of the cancer drugs approved by the U.S. Food Drug Administration. For more information, visit our Web site at www.ctrc.net.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the U.S. Phase 2 combination REOLYSIN/paclitaxel and
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
2. Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
3. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
4. Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Tenn. , Dec. 16 MedSolutions ... cost management services, today commended two new studies ... CT scans and other diagnostic imaging tests. ... to proper diagnosis and treatment," said Gregg Allen, ... new studies offer more compelling evidence that stricter ...
(Date:12/16/2009)... 16 HDT Engineered Technologies (HDT), a ... and a principal subcontractor for the mechanical development ... of new anthropromorphic arm technology that will give ... and hand, including a sense of touch. ... Projects Agency (DARPA) Revolutionizing Prosthetics 2009 (RP2009) project, ...
(Date:12/16/2009)... Inc., a Johnson & Johnson (NYSE: ... surgical care, and Acclarent, Inc., a privately held ... commercializing devices that address conditions affecting the ear, ... merger agreement whereby Ethicon will acquire Acclarent in ... of estimated cash on hand at time of ...
Breaking Medicine Technology:MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4Ann Taylor Stores Corp Returns To St Jude Childrens Research Hospitals Thanks and Giving Campaign 28R 29 For The Third Year 61935 1Ann Taylor Stores Corp Returns To St Jude Childrens Research Hospitals Thanks and Giving Campaign 28R 29 For The Third Year 61935 2ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency Savings 61933 1ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency Savings 61933 2Nothing Is Like Being There 61931 1Nothing Is Like Being There 61931 2
(Date:12/16/2009)... NORCROSS, Ga., Dec. 16 Immucor, Inc. (Nasdaq: ... instrument-reagent systems to the blood transfusion industry, today announced ... its board as a new independent director, effective January ... in blood banking and transfusion medicine for more than ... and Medicine at the University of Virginia School of ...
(Date:12/16/2009)... 16 Allscripts (Nasdaq: MDRX ) ... results for the three and six months ended ... on Monday, January 11, 2010. Allscripts management will ... the company,s earnings and other information at 8:30 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal ...
(Date:12/16/2009)... The most widely used human embryonic stem cell ... justice questions that must be addressed to ensure that ... according to a University of Michigan research team. ,, ... U-M team analyzed 47 embryonic stem cell lines, including ... researchers. The scientists determined the genetic ancestry of each ...
(Date:12/16/2009)... CHICAGO, Dec. 16 HealthSciences Institute ... health care professionals, teams and organizations who ... by, chronic diseases in employer, health plan, ... The collaborative will offer free, noncommercial webinars ... chronic disease prevention, management and care improvement. ...
(Date:12/16/2009)... to disease , , WEDNESDAY, Dec. 16 (HealthDay News) ... leprosy have been identified by scientists in Singapore ... than 10,000 DNA samples from leprosy patients and ... the important role that the innate immune response ... leprosy is not common, the discoveries have significant ...
Breaking Medicine News(10 mins):Health News:Immucor Appoints New Board Director 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Leprosy Genes Identified 2
... dreaded disease, meant death two decades ago. It still remains ... if diagnosed early. There are various types of cancer depending ... of cancer are less incident nowadays – including lung, stomach ... the day. ,According to this new study published ...
... energy bathing scheme for its population in the countryside where ... rural people bathe only once a month. ,Now energy ... rural population to the joys of a hot bath. ... bathe only once every quarter or every six months, leading ...
... lifestyle of working parents is having a toll on the health ... Centre.// ,Fast and junk food are the most favoured ... in these joints rather than have a decent cooked lunch. A ... for most middle class families in India. ,The ...
... experts and in a new move to contain the spread, ... and staff of hospitals, especially those discharging clinical care, to ... jewelry and the like. ,The rules have been ... NHS Trust, with an effort to bring down the rate ...
... Hundreds of students in Madhya Pradesh took part in an ... control the fatal virus.// ,The students tied 'suraksha ... awareness of HIV and their commitment to spread this awareness. ... the Makhanlal Chaturvedi University of Journalism here as part of ...
... of next-generation medical technology, in conjunction with MYOTECH//, ... indicate the potential of the MYO-VAD, a cardiac ... heart failure. The MYO-VAD restores cardiac output on ... be implanted in approximately three minutes. ,Researchers ...
Other Medicine News:Health News:Child Obesity and Diabetes - A Major Problem in India, 2Health News:Positive Animal Study on MYO-VAD, Promise for Treatment of Heart Failure 2
Inquire...
... Software is easy to configure ... any balance. Use the standard method or ... volume, temperature, pressure, etc.) QualiTrace automatically manages ... the measurements from the balance to the ...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile...
Reagent Basin, 60mL, 5/Box...
Medicine Products: